P. H. P. Groeneveld

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy

Anne Boerekamps, Guido E van den Berk, Fanny N. Lauw et al. · Clinical Infectious Diseases · 2017 · 171 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Antibiotic-Induced Release of Lipoteichoic Acid and Peptidoglycan from <i>Staphylococcus aureus</i> : Quantitative Measurements and Biological Reactivities

Petra van Langevelde, Jaap T. van Dissel, E. Ravensbergen et al. · Antimicrobial Agents and Chemotherapy · 1998 · 154 citations · Full text

Medicine, Microbiology, Pharmacology +13

Methylene blue increases myocardial function in septic shock

Catharina R. G. H. Daemen-Gubbels, P. H. P. Groeneveld, A. B. Johan Groeneveld et al. · Critical Care Medicine · 1995 · 122 citations

Veterinary Medicine, Pharmacology, Physiology +16

Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial

Marijn de Bruin, E. Oberjé, Wolfgang Viechtbauer et al. · The Lancet Infectious Diseases · 2017 · 110 citations · Full text

Public Health, Advanced Practice Nursing, Pharmacoeconomics +13